GENERAL, O. Reg. 203/94
Schedule 2
Cite as GENERAL, O. Reg. 203/94, Schedule 2 · current to November 11, 2026 · consolidated from May 15, 2023 · read from e-Laws on November 16, 2026
The text
Schedule 2 drugs that may be prescribed by a member (Topical and oral)
Drugs for Topical Use
Topical Antibacterial Agents — for the purpose of managing superficial bacterial infections of the foot:
Bacitracin
Framycetin sulfate
Fusidic acid
Gentamicin sulfate
Mupirocin
Silver sulfadiazine
Erythromycin
Bacitracin/neomycin sulphate
Neomycin sulphate/polymyxin B sulphate/bacitracin
Neomycin sulphate/polymyxin B sulphate/gramicidin
Topical Antifungal Agents — for the purpose of managing fungal and/or yeast infections of the skin and nails of the foot:
Ciclopirox olamine
Clotrimazole
Ketoconazole
Miconazole nitrate
Nystatin
Terbinafine HCl
Tolnaftate cream
Undecylenic acid
Efinaconazole
Clioquinol
Topical Antipruritic and Local Anesthetic Agents — for the purpose of decreasing or eliminating sensation in an area of skin of the foot to relieve inflammatory skin symptoms or prior to injection or superficial procedures:
Benzocaine
Lidocaine
Prilocaine
Topical Nonsteroidal Anti-inflammatory Agents — for the purpose of relieving inflammation and pain in structures of the foot:
Diclofenac
Ketoprofen
Piroxicam
Sulindac
Topical Corticosteroid Agents — for the purpose of treating inflammatory manifestations of corticosteroid responsive dermatoses in structures of the foot:
Amcinonide
Betamethasone diproprionate
Betamethasone valerate
Desoximetasone
Flumethasone/clioquinol
Fluocinonide
Halcinonide
Hydrocortisone
Hydrocortisone 17 valerate
Mometasone furoate
Triamcinolone acetonide
Topical Emollients, Keratolytic, and Miscellaneous Skin Agents — for the management of hyperkeratotic, inflammatory, and/or infectious skin conditions of the foot, adjunct treatment of fungal nails, and/or chemical destruction of miscellaneous skin and nail lesions:
Salicylic Acid (70% or less)
Urea (50% or less)
Ammonium lactate (12% or less)
Cantharidin (1% or less)
Silver Nitrate (95% or less)
5-Fluorouracil (5% or less)
Podophyllin (2% or less)
Lactic acid (16.7% or less)
Imiquimod (3.75% w/w)
Pimercrolimus (1% w/w)
Calcipotriol (50 mcg/g)
Collagenase
Drugs for Oral Use
Oral Penicillin Antibacterial Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Amoxicillin
Amoxicillin/Clavulanic acid
Cloxacillin
Oral First-Generation Cephalosporin Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Cefadroxil
Cephalexin
Oral Erythromycin and Macrolide Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Erythromycin
Azithromycin
Clarithromycin
Oral Quinolone Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Ciprofloxacin
Levofloxacin
Moxifloxacin
Oral Sulfonamide Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Sulfamethoxazole/trimethoprim
Oral Tetracycline Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Tetracycline
Doxycycline
Oral Lincomycins — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis:
Clindamycin
Oral Metronidazole — for the purpose of managing susceptible anaerobic bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, and abscesses:
Metronidazole
Oral Nonsteroidal Anti-Inflammatory Agents — for the purpose of relieving inflammatory conditions or pain of the foot:
Diclofenac potassium
Diclofenac sodium
Diflunisal
Ibuprofen
Indomethacin
Meloxicam
Ketorolac tromethamine (maximum daily dosage of 10 mg every 4-6 hours, as needed for pain, with the total dosage not to exceed 4 doses per day, or 40 mg in total per day, for a maximum duration of 5 days)
Naproxen
Naproxen sodium
Tiaprofenic acid
Celecoxib
Ketoprofen
Piroxicam
Sulindac
Oral Misoprostol — to be prescribed only in conjunction with Nonsteroidal Anti-inflammatory Agents for the purpose of preventing gastric bleeding, in the course of engaging in the practice of chiropody:
Misoprostol
Oral Azole Agents — for the purpose of managing fungal and/or yeast infections of the skin and nails of the foot:
Itraconazole
Fluconazole
Oral Allylamine Agents — for the purpose of managing fungal and/or yeast infections of the skin and nails of the foot:
Terbinafine
Oral First-Generation Antihistamines — for use in the management of nausea/vomiting, pruritis, urticaria, and/or allergic symptomatology, in the course of engaging in the practice of chiropody:
Diphenhydramine
Promethazine
Hydroxyzine
Oral Second-Generation Antihistamines — for use in the management of pruritis, urticaria, and/or allergic symptomatology, in the course of engaging in the practice of chiropody:
Cetirizine
Oral Histamine H2-Antagonists — to be prescribed only in conjunction with Nonsteroidal Anti-inflammatory Agents for the purpose of preventing gastric bleeding, in the course of engaging in the practice of chiropody:
Cimetidine
Nizatidine
Read the GENERAL on e-Laws ↗
Made under Chiropody Act, 1991, S.O. 1991, c. 20.